ProMab

Company Overview

ProMab Biotechnologies integrates bioinformatics, gene cloning, molecular biology, protein expression/purification techniques, microbiology, immunology, and new high-throughput technologies to manufacture recombinant proteins, monoclonal and polyclonal antibodies, overexpression and knockout cell lines, purified primary cells, CAR-T/NK cells, and mRNA-LNP. It engages in partnerships, joint ventures, and collaborations with other biotechnology and bio-reagent companies to contribute to the global biomedical research community. It is also involved in contract research with an emphasis on the function of CAR-T/NK cells in vitro and in animal disease models. ProMab Biotechnologies specializes in cutting-edge automated techniques for error-free synthesis.

Company's Business Segments

• Biotechnology Products & Services : The company offers a wide range of biotechnology products and services, including custom antibody and protein production, engineered cell lines, gene synthesis, and research services focused on immunotherapy, particularly CAR-T/NK cell and mRNA-LNP therapies.